Vidyya Medical News Service
Volume 5 Issue 175 Published - 14:00 UTC 08:00 EST 24-June-2003 Next Update - 14:00 UTC 08:00 EST 25-June-2003
little clear gif used for spacer

AIDS in India could become as dire as in Africa
The epidemic of HIV/AIDS in India is following the same pattern as that of sub-Saharan Africa in the 1980s, and it could become just as devastating unless preventive action is taken now, according to researchers from the University of California, Berkeley, in a paper to be published Saturday (June 21) in the British Medical Journal.  more

'SARS chip' free to researchers from National Institute of Allergy and Infectious Diseases
To spur research on severe acute respiratory syndrome (SARS), the National Institute of Allergy and Infectious Diseases (NIAID) today announced a free distribution program for a new "SARS chip" that will enable researchers to rapidly detect tiny genetic variations among different SARS virus strains. Today's announcement is the result of an alliance of government, not-for-profit and industry partners. more


Drug improves back pain, mobility, function in ankylosing spondylitis patients
Patients in a phase 3 clinical study assessing the efficacy and tolerability of Enbrel (etanercept) in the treatment of active ankylosing spondylitis experienced significant and rapid reduction in back pain and morning stiffness, and improvement in spinal mobility and physical function. The data are part of a presentation at the annual meeting of European League Against Rheumatism being held this week in Lisbon, Portugal.  more

Prescribing information: Enbrel (entanercept)
Enbrel is the only fully human anti-TNF receptor approved for use to reduce the signs and symptoms and inhibit the progression of structural damage in patients with moderately to severely active RA, and to reduce the signs and symptoms of active arthritis in patients with psoriatic arthritis. Enbrel is the only biologic therapy approved to treat newly diagnosed RA patients, and can be used alone. It is also approved to reduce the signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis (JRA) in patients who have had an inadequate response to disease-modifying medicines.  more

AHRQ releases new men's health tool for medical tests and tips to stay healthy at any age
Earlier this month, the Agency for Healthcare Research and Quality announced a new men's health tool, A Checklist for Your Next Checkup. The checklist shows at a glance what the U.S. Preventive Services Task Force recommends regarding seven important medical screening tests for men and offers other important information on ways to stay healthy.  more

little clear gif used for a space